Didemnins: antiviral and antitumor depsipeptides from a caribbean tunicate
- PMID: 7233187
- DOI: 10.1126/science.7233187
Didemnins: antiviral and antitumor depsipeptides from a caribbean tunicate
Abstract
Extracts of samples of a Caribbean tunicate (ascidian, sea squirt) of the family Didemnidae inhibit in vitro at low concentrations the growth of DNA and RNA viruses as well as L1210 leukemic cells. The active compounds isolated from the tunicate, didemnins A, B, and C, are depsipeptides, and didemnin B (a derivative of didemnin A) is the component active at the lowest concentration in inhibiting viral replication in vitro and P388 leukemia in vivo.
Similar articles
-
Antiviral and antitumor compounds from tunicates.Fed Proc. 1983 Jan;42(1):87-90. Fed Proc. 1983. PMID: 6681537
-
Didemnins and tunichlorin: novel natural products from the marine tunicate Trididemnum solidum.J Nat Prod. 1988 Jan-Feb;51(1):1-21. doi: 10.1021/np50055a001. J Nat Prod. 1988. PMID: 3373220
-
Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent.Invest New Drugs. 1986;4(3):279-84. doi: 10.1007/BF00179597. Invest New Drugs. 1986. PMID: 3546184 Review.
-
Structure--activity relationships of the didemnins.J Med Chem. 1996 Jul 5;39(14):2819-34. doi: 10.1021/jm960048g. J Med Chem. 1996. PMID: 8709112
-
Didemnins, tamandarins and related natural products.Nat Prod Rep. 2012 Mar;29(3):404-24. doi: 10.1039/c2np00065b. Epub 2012 Jan 23. Nat Prod Rep. 2012. PMID: 22270031 Review.
Cited by
-
Marine Natural Products from Tunicates and Their Associated Microbes.Mar Drugs. 2021 May 26;19(6):308. doi: 10.3390/md19060308. Mar Drugs. 2021. PMID: 34073515 Free PMC article. Review.
-
Marine Invertebrate Antimicrobial Peptides and Their Potential as Novel Peptide Antibiotics.Mar Drugs. 2023 Sep 23;21(10):503. doi: 10.3390/md21100503. Mar Drugs. 2023. PMID: 37888438 Free PMC article. Review.
-
Picornavirus inhibitors.Pharmacol Ther. 1994;64(2):215-90. doi: 10.1016/0163-7258(94)90040-x. Pharmacol Ther. 1994. PMID: 7533301 Free PMC article. Review.
-
Phase II evaluation of didemnin B in hormonally refractory metastatic prostate cancer. A Southwest Oncology Group study.Invest New Drugs. 1995;13(2):167-70. doi: 10.1007/BF00872867. Invest New Drugs. 1995. PMID: 8617581 Clinical Trial.
-
Synthesis of complex head-to-side-chain cyclodepsipeptides.Nat Protoc. 2016 Oct;11(10):1924-1947. doi: 10.1038/nprot.2016.116. Epub 2016 Sep 15. Nat Protoc. 2016. PMID: 27658010
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
